Ultimovacs Receives FDA Orphan Drug Designation for the UV1 Cancer Vaccine for Treatment of…
Ultimovacs ASA, a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Read More...
Read More...